We have detected that you are using some form of ad-blocking or filtering.
Please consider white-listing Labnodes since 1) ad-blockers like uBlock break Labnodes functionality and 2) Labnodes does not serve ads.
View other collections this resource is shared to.
Mark A. Magnuson, M.D.
Director, Vanderbilt Center for Stem Cell Biology
*Pancreatic Inflammation Redirects
Acinar to β Cell Reprogramming. Clayton HW, Osipovich
AB, Stancill JS, Schneider JD, Vianna PG, Shanks CM, Yuan W, Gu G,
Manduchi E, Stoeckert CJ, Magnuson MA (2016) Cell
Rep 17(8): 2028-2041.
Primary publication · 27851966 (PubMed) · PMC5131369 (PubMed Central)
Directed differentiation and genetic manipulation of embryonic stem cells
We are interested in developing new types of therapies for the treatment of diabetes. This requires a deep understanding of pancreatic beta cell function and development. My laboratory has a long history of developing novel and mouse models using gene targeting and recombinase-mediated cassette exchange (RMCE) strategies, and using these mice to gain important new insights and understanding of the molecular physiology of diabetes. However, better models that more closely mimic the physiology and pathophysiology of human diseases, including type 1 and type 2 diabetes, are needed. Towards this end, we have been developing several novel strategies and methods that will enable us to generate better animal models that more closely model the human.
© 2010-2022. All Rights Reserved to Vanderbilt University. Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Released July 13, 2020